Literature DB >> 23490635

[Good reproducibility and validity of a self-administered questionnaire evaluating adherence to the French national nutrition and health program recommendations].

Gaëlle Gusto1, Sylviane Vol, Martine Bedouet, Caroline Leglu, Peggy Decou, Emilie Beslin, Christian Guillaud, Nane Copin, Olivier Lantieri, Jean Tichet.   

Abstract

OBJECTIVES: To study the reproducibility and validity of a French self-administered questionnaire (NAQAPNNS) evaluating the adequation of a subject with the French national nutrition and health program recommendations.
METHODS: The reproducibility was estimated by weighted kappa in 48 subjects working in the administrative departments of the head office of the Institut Inter Régional pour la Santé in Tours aged from 21 to 63 years who filled the questionnaire NAQAPNNS twice with a two weeks interval. The validity was assessed in 524 hyperglycaemic subjects (fasting plasma glucose between 1.10g/l and 1.25g/l) aged from 25 to 70 years against a seven-day dietary recall using the Kruskall-Wallis test. Agreement between self-administration of the questionnaire and dietetic interview was evaluated by weighted kappa.
RESULTS: The reproducibility was "good" (kappa≥0.67) except for recommendations on breads, cereals, potatoes and legumes (kappa=0.50) and sweetened foods consumption (kappa=0.54) which showed only "satisfactory" reproducibility. For each recommendation, subjects who reached it had dietary intakes closer to dietary references intakes (P<0.03). The agreement between self-administration and dietetic interview was "good" (kappa≥0.63) except for recommendations on added fats (kappa=0.41) and salt (kappa=0.50) consumption which were only "satisfactory". DISCUSSION: The NAQAPNNS questionnaire is a consistent and reproducible tool to evaluate adequation of a subject with French national nutritional recommendations.
CONCLUSION: The self-administered questionnaire NAQAPNNS can be used in clinical practice or in epidemiological studies to detect subjects with a food imbalance and needing specific care.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23490635     DOI: 10.1016/j.lpm.2013.01.051

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Long-term Effects of Nutrition Education in Bariatric Surgery Patients.

Authors:  Marinos Fysekidis; Narcisse Kouacou; Jean Marc Catheline; Hervé Le Clésiau; Régis Cohen
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

2.  Effectiveness of an individualized home-based physical activity program in surgery-free non-endarterectomized asymptomatic stroke patients: a study protocol for the PACAPh interventional randomized trial.

Authors:  Mathilde Mura; Emeraude Rivoire; Leila Dehina-Khenniche; Michèle Weiss-Gayet; Bénédicte Chazaud; Camille Faes; Philippe Connes; Anne Long; Chantal L Rytz; Pauline Mury; Lidia Delrieu; Etienne Gouraud; Marine Bordet; Nellie Della Schiava; Patrick Lermusiaux; Matthieu Arsicot; Antoine Millon; Vincent Pialoux
Journal:  Trials       Date:  2022-02-14       Impact factor: 2.728

3.  Monocyte Phenotypes and Physical Activity in Patients with Carotid Atherosclerosis.

Authors:  Mathilde Mura; Michèle Weiss-Gayet; Nellie Della-Schiava; Erica Chirico; Patrick Lermusiaux; Marie Chambion-Diaz; Camille Faes; Anaelle Boreau; Bénédicte Chazaud; Antoine Millon; Vincent Pialoux
Journal:  Antioxidants (Basel)       Date:  2022-08-05

4.  Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancer.

Authors:  Davide Soldato; Julie Havas; Tracy E Crane; Daniele Presti; Pietro Lapidari; Nathalie Rassy; Barbara Pistilli; Elise Martin; Lucia Del Mastro; Anne-Laure Martin; Alexandra Jacquet; Charles Coutant; Paul Cottu; Asma Merimeche; Florence Lerebours; Olivier Tredan; Laurence Vanlemmens; Fabrice André; Ines Vaz-Luis; Antonio Di Meglio
Journal:  Cancer       Date:  2022-08-01       Impact factor: 6.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.